Title:
Long-acting formulation of insulin glargine
Document Type and Number:
Japanese Patent JP6333775
Kind Code:
B2
Abstract:
The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.
Inventors:
Reinhard Becker
Anke Flick
Peter Boderke
Chrisziane Furst
Werner Mueller
Katrin Telchu
Ulrich Werner
Petra Loin
Isabelle Sette
Anke Flick
Peter Boderke
Chrisziane Furst
Werner Mueller
Katrin Telchu
Ulrich Werner
Petra Loin
Isabelle Sette
Application Number:
JP2015112917A
Publication Date:
May 30, 2018
Filing Date:
June 03, 2015
Export Citation:
Assignee:
SANOFI
International Classes:
A61K38/28; A61K9/08; A61K47/02; A61K47/10; A61K47/34; A61P3/10
Domestic Patent References:
| JP2005532365A | ||||
| JP2005508895A |
Other References:
DIABETES METAB.RES.REV.,2007年,VOL.23,P.265-268
DIABETES RESEARCH AND CLINICAL PRACTICE,2000年,VOL.50,P.161-16
USE OF U-500 REGULAR INSULIN IN TYPE 2 DIABETES,DIABETES CARE,2006年,VOL.29,NO.9,P.2175-2176
BR.J.DIABETES VASC.DIS.2010年 2月,VOL.10,NO.1,P.21-30
DIABETES RESEARCH AND CLINICAL PRACTICE,2000年,VOL.50,P.161-16
USE OF U-500 REGULAR INSULIN IN TYPE 2 DIABETES,DIABETES CARE,2006年,VOL.29,NO.9,P.2175-2176
BR.J.DIABETES VASC.DIS.2010年 2月,VOL.10,NO.1,P.21-30
Attorney, Agent or Firm:
Junji Yuda
Noriyuki Takebayashi
Noriyuki Takebayashi